Yahoo Web Search

Search results

1. BridgeBio Pharma, Inc.

   NasdaqGS: BBIO

   25.56

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.10 (-0.39%)

   At close:4:00 PM EDTWed. Aug 21, 2024

   25.80 +0.24 (+0.94%)

   Pre mkt:8:31 AM EDTThu. Aug 22, 2024

   Nasdaq Real Time Price (USD) · Pre-Market Time

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	25.60
     High	26.00
     Low	24.83

   • Mkt Cap	4.81B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	25.66
     52 Wk. Low	21.62
     52 Wk. High	44.32

   More about BBIO

   Related stocks

   • APLS
     Apellis Pharmaceuticals, Inc.
     APLS
     39.85
     +2.32%
   • AKRO
     Akero Therapeutics, Inc.
     AKRO
     26.35
     -1.46%
   • ALLK
     Allakos Inc.
     ALLK
     0.7474
     +5.52%
   • DNLI
     Denali Therapeutics Inc.
     DNLI
     25.00
     +5.71%
   • BPMC
     Blueprint Medicines Corporation
     BPMC
     94.78
     +1.70%

   More on Yahoo Finance

2. finance.yahoo.com › news › 47-stake-nuvation-bio-incWith 47% stake, Nuvation Bio Inc. (NYSE:NUVB ... - Yahoo Finance

   finance.yahoo.com › news › 47-stake-nuvation-bio-inc

   • Cached

   13 hours ago · Key Insights. Given the large stake in the stock by institutions, Nuvation Bio's stock price might be vulnerable to their trading decisions. 55% of the business is held by the top 5 shareholders

3. People also ask

   What are bbio share price forecasts?

   • Their BBIO share price forecasts range from $18.00 to $60.00. On average, they anticipate the company's stock price to reach $37.30 in the next year. This suggests a possible upside of 41.4% from the stock's current price. View analysts price targets for BBIO or view top-rated stocks among Wall Street analysts.

   BridgeBio Pharma Stock Forecast, Price & News (NASDAQ:BBIO) - Mark…

   www.marketbeat.com/stocks/NASDAQ/BBIO/

   See all results for this question

   What's happening with bbio stock?

   • B ridgeBio Pharma (BBIO) closed the most recent trading day at $10.02, moving +0.1% from the previous trading session. The stock outpaced the S&P 500's daily loss of 2.77%.

   BridgeBio Pharma (BBIO) Gains As Market Dips: What You Should Know

   www.nasdaq.com/articles/bridgebio-pharma-bbio-gains-as-market-dips:-what-you-should-know

   See all results for this question

   Is bbio (bbio) a sell?

   • Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review (s). Turning to the stock’s technical picture we see that short term indicators suggest on average that BBIO is a 50% Sell.

   Volatility Hits 8.64% At BridgeBio Pharma Inc. (BBIO) – Here’s What A G…

   stocksregister.com/2023/01/13/volatility-hits-8-64-at-bridgebio-pharma-inc-bbio-heres-what-a-good-investor-should-do/

   See all results for this question

   Is CBIO stock a buy?

   • CBIO has decreased by -55.81% in the past year and price targets may not have had time to catch up. According to 9 stock analysts, the average 12-month stock price forecast for CBIO stock is $ 16.32 , which predicts an increase of 6,995.65%. The lowest target is $ 16.16 and the highest is $ 16.8. On average, analysts rate CBIO stock as a buy.

   Catalyst Biosciences, Inc. (CBIO) Forecast & Price Targets - Stock Analysis

   stockanalysis.com/stocks/cbio/forecast/

   See all results for this question